Cargando…

853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study

BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanure, Luciana Coelho, Pinho, Rafaela Tonholli, Alves, Érico Macedo Pacheco, Pires, Bárbara Caldeira, Lopes, Joice Ribeiro, Ribeiro, Daniela Teixeira, de Souza, Flávio Henrique Batista, Couto, Braulio Roberto Gonçalves Marinho, Starling, Carlos Ernesto Ferreira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776628/
http://dx.doi.org/10.1093/ofid/ofaa439.1042
_version_ 1783630727538016256
author Tanure, Luciana Coelho
Pinho, Rafaela Tonholli
Alves, Érico Macedo Pacheco
Pires, Bárbara Caldeira
Lopes, Joice Ribeiro
Ribeiro, Daniela Teixeira
de Souza, Flávio Henrique Batista
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
author_facet Tanure, Luciana Coelho
Pinho, Rafaela Tonholli
Alves, Érico Macedo Pacheco
Pires, Bárbara Caldeira
Lopes, Joice Ribeiro
Ribeiro, Daniela Teixeira
de Souza, Flávio Henrique Batista
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
author_sort Tanure, Luciana Coelho
collection PubMed
description BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given that the microorganism is multi resistant to most antimicrobials available, especially vancomycin. Therefore, the present study is built from and analyzes the data of VRE, collected by the Infection Prevetion and Control Service of hospitals in Brazil, to clarify: the incidence rate, the gross lethality of these infections and what are the profiles of infected patients. METHODS: Collection and analysis of epidemiological data, according to the National Healthcare Safety Network (NHSN) protocol of the Centers for Disease Control and Prevention (CDC), in 10 hospitals in Brazil, between Jan/2017 - Dec/2019. RESULTS: In three years, 118 VRE infections were diagnosed in the hospitals analyzed: 51 from ICU (43%), 24 from Vascular Acess (20%), 18 from General Clinic (15%), 10 from General Surgery (8%) and 15 from Others (13%). Patients ages ranged from 0 to 93 years, with a mean of 62 years (standard deviation of 20 years) and a median of 66 years. Time between admission and diagnosis of infection was 1 to 1001 days, with a mean of 68 days (standard deviation of 25 days) and a median of 59 days. The gross lethality for VRE infections was 47/118 (40%). The infection sites were: Bloodstream Infections – BSI = 34 (29%); Urinary Tract Infections – UTI = 28 (24%); Surgical Site Infections – SSI = 27 (23%); Skin and Soft Tissue Infections – SST = 14 (12%); Bone and Joint Infections – BJ = 5 (4%); Cardiovascular System Infections – CVS = 5 (4%); Lower Respiratory System Infections, other than pneumonia – LRI = 2 (2%); Pneumonia – PNEU = 2 (2%) and Gastrointestinal System Infections – GI = 1 (1%). Percentage of VRE infections by hospital units [Image: see text] Percentage of VRE infections by infection sites [Image: see text] Infection sites of VRE infections by hospital [Image: see text] CONCLUSION: VRE infection is a highly lethal event that usually occurs after two months of hospitalization. The main site of infection is the BSI, with a higher incidence in patients over 62 years or the ones in ICU. Early and accurate investigations of multiresistant microorganisms in a hospital setting are necessary to reduce patient morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7776628
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77766282021-01-07 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study Tanure, Luciana Coelho Pinho, Rafaela Tonholli Alves, Érico Macedo Pacheco Pires, Bárbara Caldeira Lopes, Joice Ribeiro Ribeiro, Daniela Teixeira de Souza, Flávio Henrique Batista Couto, Braulio Roberto Gonçalves Marinho Starling, Carlos Ernesto Ferreira Open Forum Infect Dis Poster Abstracts BACKGROUND: Vancomycin-Resistant Enterococcus (VRE) is considered one of the main pathogens of hospital-acquired infections (HAI), responsible for high morbidity and mortality rates. HAI caused by this bacteria, especially in intensive care units (ICU), are concerning for the health system, given that the microorganism is multi resistant to most antimicrobials available, especially vancomycin. Therefore, the present study is built from and analyzes the data of VRE, collected by the Infection Prevetion and Control Service of hospitals in Brazil, to clarify: the incidence rate, the gross lethality of these infections and what are the profiles of infected patients. METHODS: Collection and analysis of epidemiological data, according to the National Healthcare Safety Network (NHSN) protocol of the Centers for Disease Control and Prevention (CDC), in 10 hospitals in Brazil, between Jan/2017 - Dec/2019. RESULTS: In three years, 118 VRE infections were diagnosed in the hospitals analyzed: 51 from ICU (43%), 24 from Vascular Acess (20%), 18 from General Clinic (15%), 10 from General Surgery (8%) and 15 from Others (13%). Patients ages ranged from 0 to 93 years, with a mean of 62 years (standard deviation of 20 years) and a median of 66 years. Time between admission and diagnosis of infection was 1 to 1001 days, with a mean of 68 days (standard deviation of 25 days) and a median of 59 days. The gross lethality for VRE infections was 47/118 (40%). The infection sites were: Bloodstream Infections – BSI = 34 (29%); Urinary Tract Infections – UTI = 28 (24%); Surgical Site Infections – SSI = 27 (23%); Skin and Soft Tissue Infections – SST = 14 (12%); Bone and Joint Infections – BJ = 5 (4%); Cardiovascular System Infections – CVS = 5 (4%); Lower Respiratory System Infections, other than pneumonia – LRI = 2 (2%); Pneumonia – PNEU = 2 (2%) and Gastrointestinal System Infections – GI = 1 (1%). Percentage of VRE infections by hospital units [Image: see text] Percentage of VRE infections by infection sites [Image: see text] Infection sites of VRE infections by hospital [Image: see text] CONCLUSION: VRE infection is a highly lethal event that usually occurs after two months of hospitalization. The main site of infection is the BSI, with a higher incidence in patients over 62 years or the ones in ICU. Early and accurate investigations of multiresistant microorganisms in a hospital setting are necessary to reduce patient morbidity and mortality. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776628/ http://dx.doi.org/10.1093/ofid/ofaa439.1042 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Tanure, Luciana Coelho
Pinho, Rafaela Tonholli
Alves, Érico Macedo Pacheco
Pires, Bárbara Caldeira
Lopes, Joice Ribeiro
Ribeiro, Daniela Teixeira
de Souza, Flávio Henrique Batista
Couto, Braulio Roberto Gonçalves Marinho
Starling, Carlos Ernesto Ferreira
853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title_full 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title_fullStr 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title_full_unstemmed 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title_short 853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
title_sort 853. hospital-acquired infections by vancomycin-resistant enterococcus (vre): results in 3 years of multicenter study
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776628/
http://dx.doi.org/10.1093/ofid/ofaa439.1042
work_keys_str_mv AT tanurelucianacoelho 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT pinhorafaelatonholli 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT alvesericomacedopacheco 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT piresbarbaracaldeira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT lopesjoiceribeiro 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT ribeirodanielateixeira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT desouzaflaviohenriquebatista 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT coutobrauliorobertogoncalvesmarinho 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy
AT starlingcarlosernestoferreira 853hospitalacquiredinfectionsbyvancomycinresistantenterococcusvreresultsin3yearsofmulticenterstudy